Colorectal cancer is one of the leading causes of death in the United States, with an estimated 134,490 new cases and 49,190 deaths in 2020 alone.1 Early detection and treatment of colorectal cancer is essential to improving outcomes, and flexible sigmoidoscopy has been identified as a revolutionary way to detect colorectal cancer in its early stages. Flexible sigmoidoscopy is a safe, non-invasive procedure that provides an effective way to detect colorectal cancer in its earliest stages, when it is most treatable. In this article, we will explore the benefits of flexible sigmoidoscopy as a revolutionary way to detect colorectal cancer.
Flexible sigmoidoscopy is a procedure that uses a thin, flexible tube with a light and camera on the end to examine the inside of the lower part of the colon, or sigmoid colon. The procedure is performed by a doctor, and typically takes only a few minutes. During the procedure, the doctor will insert the tube into the rectum and move it around to examine the inside of the sigmoid colon. The doctor will be able to view any abnormalities or growths on the inside of the sigmoid colon, and can take a biopsy if needed.
Flexible sigmoidoscopy is a safe, non-invasive procedure that provides an effective way to detect colorectal cancer in its earliest stages, when it is most treatable. The procedure is relatively quick and easy to perform, and does not require any sedation. Additionally, the procedure is relatively inexpensive compared to other colorectal cancer screening methods. Flexible sigmoidoscopy is also beneficial because it can detect polyps, which are small growths in the lining of the colon that can become cancerous. Polyps can be removed during the procedure, which can help to prevent colorectal cancer from developing. Additionally, the procedure can detect colorectal cancer in its earliest stages, when it is most treatable.
Flexible sigmoidoscopy is recommended for people aged 50 and older, and those who are at an increased risk for colorectal cancer. People who are at an increased risk for colorectal cancer include those with a family history of the disease, those with inflammatory bowel disease, and those who have had previous polyps removed. Additionally, people with certain genetic conditions, such as Lynch syndrome, are at an increased risk for colorectal cancer and should consider getting a flexible sigmoidoscopy.
Flexible sigmoidoscopy is a revolutionary way to detect colorectal cancer in its earliest stages, when it is most treatable. The procedure is safe, non-invasive, and relatively inexpensive, and can detect polyps and other abnormalities in the lining of the sigmoid colon. Flexible sigmoidoscopy is recommended for people aged 50 and older, and those who are at an increased risk for colorectal cancer. Early detection and treatment of colorectal cancer is essential to improving outcomes, and flexible sigmoidoscopy can help to ensure that the disease is detected and treated in its earliest stages.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation